Viral hepatitis
- PMID: 16447286
- DOI: 10.1002/hep.21030
Viral hepatitis
Similar articles
-
[PEG-interferons: significance for the treatment of viral hepatitis B and C].Dtsch Med Wochenschr. 2001 Jun 1;126 Suppl 1:S68-75. doi: 10.1055/s-2001-14495. Dtsch Med Wochenschr. 2001. PMID: 11450618 Review. German. No abstract available.
-
[Treatment for chronic hepatitis C, more opportunity, more challenge].Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):481-3. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19912676 Chinese. No abstract available.
-
Chronic hepatitis C virus infection.JAMA. 2003 May 14;289(18):2413-7. doi: 10.1001/jama.289.18.2413. JAMA. 2003. PMID: 12746366 Review. No abstract available.
-
PEG-IFN and ribavirin re-treatment of HCV-1b cirrhosis non responder to conventional combination therapy.Dig Liver Dis. 2008 May;40(5):391-2. doi: 10.1016/j.dld.2007.12.010. Epub 2008 Mar 4. Dig Liver Dis. 2008. PMID: 18291731 No abstract available.
-
Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.AIDS. 2006 Nov 14;20(17):2225-7. doi: 10.1097/01.aids.0000247583.38943.95. AIDS. 2006. PMID: 17086063 No abstract available.
Cited by
-
Expression and Ni-NTA-Agarose Purification of Recombinant Hepatitis C Virus E2Ectodomain Produced in a Baculovirus Expression System.Bio Protoc. 2018 Oct 5;8(19):e3030. doi: 10.21769/BioProtoc.3030. eCollection 2018 Oct 5. Bio Protoc. 2018. PMID: 34532509 Free PMC article.
-
Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.PLoS One. 2013 Dec 6;8(12):e74900. doi: 10.1371/journal.pone.0074900. eCollection 2013. PLoS One. 2013. PMID: 24324573 Free PMC article. Clinical Trial.
-
Characterization of antigenic variants of hepatitis C virus in immune evasion.Virol J. 2011 Jul 29;8:377. doi: 10.1186/1743-422X-8-377. Virol J. 2011. PMID: 21801418 Free PMC article.
-
Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.J Gen Virol. 2012 Feb;93(Pt 2):247-258. doi: 10.1099/vir.0.037903-0. Epub 2011 Nov 9. J Gen Virol. 2012. PMID: 22071510 Free PMC article.
-
Type of pegylated interferon matters: another milestone in the treatment of hepatitis C virus infection.Hepat Mon. 2010 Summer;10(3):165-7. Epub 2010 Sep 1. Hepat Mon. 2010. PMID: 22308133 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources